Celldex Therapeutics (CLDX) Short Interest Ratio & Short Volume

$44.56

+0.70 (+1.60%)

(As of 07/26/2024 ET)

Compare

Celldex Therapeutics Short Interest Data

Current Short Interest: 7,390,000 shares
Previous Short Interest: 6,990,000 shares
Change Vs. Previous Month: +5.72%
Dollar Volume Sold Short: $292.27 million
Short Interest Ratio: 11.5 Days to Cover
Last Record Date: July 15, 2024

Outstanding Shares: 65,910,000 shares
Percentage of Shares Shorted: 11.21%
Today's Trading Volume: 1,052,059 shares
Average Trading Volume: 783,855 shares
Today's Volume Vs. Average: 134%

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Short Selling Celldex Therapeutics ?

Sign up to receive the latest short interest report for Celldex Therapeutics and its competitors with MarketBeat's FREE newsletter.

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

CLDX Short Interest Over Time

CLDX Days to Cover Over Time

CLDX Percentage of Float Shorted Over Time

Ad Crypto Swap Profits

625,000% Gain

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

Celldex Therapeutics Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
7/15/2024	7,390,000 shares	$292.27 million	+5.7%	N/A	11.5	$39.55
6/30/2024	6,990,000 shares	$258.70 million	+8.7%	N/A	10.9	$37.01
6/15/2024	6,430,000 shares	$222.93 million	+2.6%	N/A	10.1	$34.67
5/31/2024	6,270,000 shares	$208.79 million	-5.3%	N/A	9.1	$33.30
5/15/2024	6,620,000 shares	$265.93 million	-5.3%	N/A	7.4	$40.17
4/30/2024	6,990,000 shares	$261.57 million	+3.6%	N/A	7.7	$37.42
Get the Latest News and Ratings for CLDX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Celldex Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
4/15/2024	6,750,000 shares	$263.72 million	+2.9%	N/A	7.3	$39.07
3/31/2024	6,560,000 shares	$275.32 million	+11.2%	N/A	6.9	$41.97
3/15/2024	5,900,000 shares	$247.86 million	-8.0%	N/A	6.4	$42.01
2/29/2024	6,410,000 shares	$308.06 million	-7.6%	N/A	7.4	$48.06
2/15/2024	6,940,000 shares	$255.39 million	+3.4%	N/A	9.3	$36.80
1/31/2024	6,710,000 shares	$236.33 million	+7.9%	N/A	8.5	$35.22
1/15/2024	6,220,000 shares	$261.49 million	-5.6%	N/A	7.6	$42.04
12/31/2023	6,590,000 shares	$261.36 million	-10.3%	N/A	8.6	$39.66
12/15/2023	7,350,000 shares	$273.05 million	-8.9%	N/A	9.6	$37.15
11/30/2023	8,070,000 shares	$243.79 million	+2.4%	N/A	11.1	$30.21
11/15/2023	7,880,000 shares	$224.82 million	+40.2%	N/A	11.3	$28.53
10/31/2023	5,620,000 shares	$132.18 million	+0.9%	N/A	9.2	$23.52
10/15/2023	5,570,000 shares	$145.60 million	-3.3%	N/A	12.1	$26.14
9/30/2023	5,760,000 shares	$158.52 million	-5.4%	N/A	13.1	$27.52
9/15/2023	6,090,000 shares	$170.22 million	-3.3%	N/A	14.3	$27.95
8/31/2023	6,300,000 shares	$175.77 million	-3.7%	N/A	13.5	$27.90
8/15/2023	6,540,000 shares	$205.55 million	+8.5%	N/A	14.3	$31.43
7/31/2023	6,030,000 shares	$213.22 million	-3.8%	N/A	13.8	$35.36
7/15/2023	6,270,000 shares	$233.81 million	+1.8%	N/A	13.5	$37.29
6/30/2023	6,160,000 shares	$209.01 million	+2.7%	N/A	11	$33.93
6/15/2023	6,000,000 shares	$221.22 million	+3.5%	N/A	9.8	$36.87
5/31/2023	5,800,000 shares	$184.44 million	+7.0%	N/A	9.3	$31.80
5/15/2023	5,420,000 shares	$185.69 million	+1.1%	N/A	8.4	$34.26
4/30/2023	5,360,000 shares	$168.52 million	+3.5%	N/A	8.4	$31.44
4/15/2023	5,180,000 shares	$156.90 million	-1.7%	N/A	8.6	$30.29
3/31/2023	5,270,000 shares	$189.61 million	+38.0%	N/A	9.9	$35.98
3/15/2023	3,820,000 shares	$167.13 million	+5.5%	N/A	8	$43.75
2/28/2023	3,620,000 shares	$154.90 million	+4.3%	N/A	7.5	$42.79
2/15/2023	3,470,000 shares	$148.79 million	+4.5%	N/A	7.7	$42.88
1/31/2023	3,320,000 shares	$146.28 million	-4.3%	N/A	6.8	$44.06
1/15/2023	3,470,000 shares	$159.69 million	+1.8%	N/A	7	$46.02
12/30/2022	3,410,000 shares	$151.98 million	-17.2%	N/A	6.8	$44.57
12/15/2022	4,120,000 shares	$182.47 million	+1.7%	N/A	8	$44.29
11/30/2022	4,050,000 shares	$150.21 million	-1.9%	N/A	9	$37.09
“Generational Bull Run” Incoming (Ad) LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event. You can find out what they are by clicking here now.
11/15/2022	4,130,000 shares	$151.53 million	-8.2%	N/A	9	$36.69
10/31/2022	4,500,000 shares	$158.09 million	-0.9%	N/A	9.7	$35.13
10/15/2022	4,540,000 shares	$142.74 million	-1.5%	N/A	9.3	$31.44
9/30/2022	4,610,000 shares	$129.59 million	+2.4%	N/A	9	$28.11
9/15/2022	4,500,000 shares	$136.40 million	+2.3%	N/A	6.2	$30.31
8/31/2022	4,400,000 shares	$133.76 million	+4.0%	N/A	5.6	$30.40
8/15/2022	4,230,000 shares	$158.92 million	+14.3%	N/A	5.1	$37.57
7/31/2022	3,700,000 shares	$113.66 million	-2.9%	30.7%	4.3	$30.72
7/15/2022	3,810,000 shares	$111.79 million	-0.3%	31.6%	4.5	$29.34
6/30/2022	3,820,000 shares	$102.99 million	-18.9%	31.7%	4.7	$26.96
6/15/2022	4,710,000 shares	$104.99 million	+1.5%	39.0%	7.3	$22.29
5/31/2022	4,640,000 shares	$109.13 million	-5.5%	N/A	8	$23.52
5/15/2022	4,910,000 shares	$147.25 million	-1.0%	N/A	8.7	$29.99
4/30/2022	4,960,000 shares	$151.53 million	-9.3%	N/A	9	$30.55
4/15/2022	5,470,000 shares	$196.04 million	-0.2%	N/A	9.8	$35.84
3/31/2022	5,480,000 shares	$186.65 million	-8.7%	N/A	9.3	$34.06
3/15/2022	6,000,000 shares	$187.26 million	+3.3%	N/A	10.3	$31.21
2/28/2022	5,810,000 shares	$173.72 million	+11.7%	N/A	10	$29.90
2/15/2022	5,200,000 shares	$169.78 million	+2.4%	N/A	9.4	$32.65
1/31/2022	5,080,000 shares	$157.53 million	+3.3%	N/A	9.9	$31.01
1/15/2022	4,920,000 shares	$157.00 million	+3.1%	N/A	0	$31.91
12/31/2021	4,770,000 shares	$184.31 million	+9.9%	N/A	10.6	$38.64
12/15/2021	4,340,000 shares	$166.92 million	+6.6%	N/A	10.1	$38.46
11/30/2021	4,070,000 shares	$155.07 million	+12.4%	N/A	9.7	$38.10
11/15/2021	3,620,000 shares	$155.70 million	-2.7%	N/A	8.2	$43.01
10/29/2021	3,720,000 shares	$158.25 million	+25.7%	N/A	7.9	$42.54
10/15/2021	2,960,000 shares	$136.69 million	-0.7%	N/A	5.7	$46.18
9/30/2021	2,980,000 shares	$160.89 million	-11.0%	N/A	3.8	$53.99
9/15/2021	3,350,000 shares	$178.25 million	-15.4%	N/A	3.7	$53.21
8/31/2021	3,960,000 shares	$208.49 million	-8.1%	N/A	4.4	$52.65
8/13/2021	4,310,000 shares	$188.43 million	+15.2%	N/A	4.9	$43.72
7/30/2021	3,740,000 shares	$163.63 million	+11.6%	N/A	4.5	$43.75
7/15/2021	3,350,000 shares	$146.93 million	+19.2%	N/A	4.2	$43.86
6/30/2021	2,810,000 shares	$93.97 million	+11.1%	7.3%	4.1	$33.44
6/15/2021	2,530,000 shares	$73.88 million	-18.4%	6.6%	4.4	$29.20
5/28/2021	3,100,000 shares	$86.65 million	-3.7%	8.1%	5.3	$27.95
5/14/2021	3,220,000 shares	$80.53 million	-3.0%	N/A	5.2	$25.01
4/30/2021	3,320,000 shares	$103.82 million	-3.8%	N/A	5	$31.27
4/15/2021	3,450,000 shares	$76.83 million	-3.1%	N/A	4.9	$22.27
3/31/2021	3,560,000 shares	$70.24 million	+24.9%	N/A	4.9	$19.73
3/15/2021	2,850,000 shares	$72.33 million	-0.7%	N/A	4.3	$25.38
2/26/2021	2,870,000 shares	$78.95 million	-16.6%	N/A	4.4	$27.51
2/12/2021	3,440,000 shares	$81.70 million	-2.0%	N/A	4.9	$23.75
1/29/2021	3,510,000 shares	$72.80 million	-1.7%	N/A	5.2	$20.74
1/15/2021	3,570,000 shares	$64.19 million	-25.8%	N/A	5.6	$17.98
12/31/2020	4,810,000 shares	$86.00 million	+118.6%	N/A	7.9	$17.88
12/15/2020	2,200,000 shares	$40.13 million	-9.5%	N/A	3	$18.24
11/30/2020	2,430,000 shares	$55.28 million	-13.8%	N/A	3.4	$22.75
11/15/2020	2,820,000 shares	$56.32 million	-5.4%	N/A	4.1	$19.97
10/30/2020	2,980,000 shares	$45.83 million	-8.0%	N/A	4.5	$15.38
“Generational Bull Run” Incoming (Ad) LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event. You can find out what they are by clicking here now.
10/15/2020	3,240,000 shares	$52.91 million	-1.5%	N/A	4.6	$16.33
9/30/2020	3,290,000 shares	$48.79 million	+9.7%	N/A	4.3	$14.83
9/15/2020	3,000,000 shares	$35.19 million	+23.5%	N/A	4.4	$11.73
8/31/2020	2,430,000 shares	$29.01 million	+102.5%	N/A	0.9	$11.94
8/14/2020	1,200,000 shares	$12.37 million	+52.5%	N/A	0.4	$10.31
7/31/2020	787,000 shares	$8.10 million	-17.3%	N/A	0.3	$10.29
7/15/2020	951,200 shares	$10.21 million	-37.8%	N/A	0.3	$10.73
6/30/2020	1,530,000 shares	$19.89 million	-33.8%	N/A	0.6	$13.00
6/15/2020	2,310,000 shares	$24.74 million	+668.2%	N/A	0.9	$10.71
5/29/2020	300,700 shares	$796,855.00	+13.8%	N/A	0.7	$2.65
5/15/2020	264,200 shares	$597,092.00	-13.9%	N/A	0.7	$2.26
4/30/2020	306,700 shares	$751,415.00	-2.6%	N/A	0.7	$2.45
4/15/2020	314,900 shares	$588,863.00	-2.4%	N/A	0.8	$1.87
3/31/2020	322,500 shares	$970,725.00	-22.3%	N/A	1	$3.01
3/13/2020	415,100 shares	$751,331.00	+8.9%	N/A	2.1	$1.81
2/28/2020	381,100 shares	$594,516.00	+56.1%	N/A	1.3	$1.56
2/14/2020	244,100 shares	$539,461.00	-8.2%	N/A	0.9	$2.21
1/31/2020	266,000 shares	$694,260.00	-6.3%	N/A	1.9	$2.61
1/15/2020	283,900 shares	$652,970.00	-8.4%	N/A	1.8	$2.30
12/31/2019	309,800 shares	$709,442.00	-11.7%	N/A	2.1	$2.29
9/15/2019	594,300 shares	$1.28 million	-33.5%	4.0%	4	$2.16
8/15/2019	1,190,500 shares	$2.76 million	+16.6%	9.9%	5.3	$2.32

CLDX Short Interest - Frequently Asked Questions

What is Celldex Therapeutics' current short interest?: Short interest is the volume of Celldex Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 7,390,000 shares of CLDX short. Learn More on Celldex Therapeutics' current short interest.
What is a good short interest ratio for Celldex Therapeutics?: The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLDX shares currently have a short interest ratio of 12.0. Learn More on Celldex Therapeutics's short interest ratio.
Which institutional investors are shorting Celldex Therapeutics?: As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Celldex Therapeutics: Walleye Trading LLC, Ikarian Capital LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.
Is Celldex Therapeutics' short interest increasing or decreasing?: Celldex Therapeutics saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 7,390,000 shares, an increase of 5.7% from the previous total of 6,990,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Celldex Therapeutics' short interest compare to its competitors?: Here is how the short interest of companies compare to Celldex Therapeutics: Intellia Therapeutics, Inc. (14.36%), Riot Platforms, Inc. (18.95%), Neogen Co. (11.44%), Aspira Women's Health Inc. (3.51%), Lantheus Holdings, Inc. (6.61%), Exact Sciences Co. (7.58%), Ionis Pharmaceuticals, Inc. (6.98%), Repligen Co. (8.14%), Halozyme Therapeutics, Inc. (6.92%), Exelixis, Inc. (3.18%),
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks.
What does it mean to sell short Celldex Therapeutics stock?: Short selling CLDX is an investing strategy that aims to generate trading profit from Celldex Therapeutics as its price is falling. CLDX shares are trading up $0.70 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against Celldex Therapeutics?: A short squeeze for Celldex Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CLDX, which in turn drives the price of the stock up even further.
How often is Celldex Therapeutics' short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLDX, twice per month. The most recent reporting period available is July, 15 2024.